Osteoprotegerin A Physiological and Pharmacological Inhibitor of Bone Resorption.
Journal:
Current Pharmaceutical Design
Volume:
7
Page:
613-635
Author(s):
Paul J. Kostenuik and victoria Shalhoub
Alphavirus Vectors for Gene Therapy Applications
Journal:
Current Gene Therapy
Volume:
1
Page:
19-29
Author(s):
Kenneth Lundstrom
The Use of Fas Ligand, TRAIL and Bax in Gene Therapy of Prostate Cancer
Journal:
Current Gene Therapy
Volume:
1
Page:
123-136
Author(s):
J. S. Norris, M. L. Hyer, C. Voelkel-Johnson, S. L. Lowe, S. Rubinchik and J-Y. Dong
Peptides as Carrier for Tumor Diagnosis and Treatment
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
1
Page:
71-93
Author(s):
M. Langer and A. G. Beck-Sickinger
Carbonic Anhydrase Inhibitors
Journal:
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents
Volume:
1
Page:
61-97
Author(s):
Claudiu T. Supuran and Andrea Scozzafava
Signal Transduction Pathways and Transcriptional Mechanisms as Targets for Prevention of Emergence of Multidrug Resistance in Human Cancer Cells
Journal:
Current Drug Targets
Volume:
2
Page:
57-77
Author(s):
Alexander A. Shtil
Microdissection and the Study of Cancer Pathways
Journal:
Current Molecular Medicine
Volume:
1
Page:
153-162
Author(s):
Anirban Maitra, Ignacio I. Wistuba and Adi F. Gazdar
Preface
Journal:
Current Pharmaceutical Biotechnology
Volume:
2
Page:
i-i
Author(s):
Alain Rolland
Nonviral Gene Therapy and its Delivery Systems
Journal:
Current Pharmaceutical Biotechnology
Volume:
2
Page:
1-17
Author(s):
Haiching Ma and Scott L. Diamond
Antibody Engineering for Targeted Therapy of Cancer Recombinant Fv-Immunotoxins
Journal:
Current Pharmaceutical Biotechnology
Volume:
2
Page:
19-46
Author(s):
Revital Niv, Cyril J. Cohen, Galit Denkberg, Dina Segal and Yoram Reiter